Egypt reserved doses of much-awaited Pfizer and Oxford trial vaccines, says Health minister

Egypt reserved doses of much-awaited Pfizer and Oxford trial vaccines, says Health minister

Egypt has reserved doses of a potential Coronavirus vaccine developed by the US Pfizer pharmaceutical corporation, which would cover up to 20 percent of the country's needs, Health Minister Hala Zayed in statement reported by local media on Tuesday.

Egypt has also secured doses of a promising British vaccine developed by Oxford University that will meet around 30 percent of the country's needs, the minister said.

According to the World Health Organization, there is no approved vaccine for the disease as of yet, which has so far killed 6,380 people and infected 109,422 others nationwide; and killed over one million people and infected more than 51 million others globally.

Both anticipated vaccines, which are still subject to trials, have reached advanced stages in many countries and show promising